BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23609419)

  • 21. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report.
    Chang K; Liu JH; Yu SC; Lin CW
    Hum Pathol; 2018 Apr; 74():114-121. PubMed ID: 29107667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical Significance of FGFR1 Gene Abnormalities in Blood Tumors].
    Zhang CL; Tang GS; Guo MQ; Cheng H; Liu MD; Yang JM; Gong SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):983-988. PubMed ID: 32552969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
    Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
    Zhou J; Papenhausen P; Shao H
    Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
    Duckworth CB; Zhang L; Li S
    Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
    Kim SY; Kim JE; Park S; Kim HK
    Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.
    Chang H; Chuang WY; Sun CF; Barnard MR
    Diagn Pathol; 2012 Feb; 7():19. PubMed ID: 22356850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with
    Freyer CW; Hughes ME; Carulli A; Bagg A; Hexner E
    Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.
    Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Hematology; 2018 Sep; 23(8):470-477. PubMed ID: 29486661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
    Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-needle aspiration cytology of T-lymphoblastic lymphoma associated FGFR1 rearrangement myeloproliferative neoplasm.
    Patel RA; Sheehan AM; Finch CJ; Lopez-Terrada D; Hernandez VS; Curry CV
    Diagn Cytopathol; 2014 Jan; 42(1):45-8. PubMed ID: 23904402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11).
    Wang T; Wang Z; Zhang L; Wen L; Cai W; Yang X; Pan J; Ruan C; Wu D; Sun A; Chen S
    Br J Haematol; 2020 Jan; 188(1):177-181. PubMed ID: 31802477
    [No Abstract]   [Full Text] [Related]  

  • 37. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
    Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
    Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy chain gene rearrangement.
    Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Mushino T; Kuriyama K; Tamura S; Hatanaka K; Hanaoka N; Nakakuma H
    Acta Haematol; 2013; 129(4):238-42. PubMed ID: 23328683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
    Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
    Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.